v3.26.3
Offerings - Offering: 1
Nov. 16, 2026
USD ($)
shares
Offering:  
Fee Previously Paid false
Other Rule true
Security Type Equity
Security Class Title Common Stock
Amount Registered | shares 6,610,923
Proposed Maximum Offering Price per Unit 0.9205
Maximum Aggregate Offering Price $ 6,085,354.62
Fee Rate 0.0087%
Amount of Registration Fee $ 529.43
Offering Note Pursuant to Rule 416 of the Securities Act of 1933, the registration statement on Form S-8 to which this exhibit relates (the "Registration Statement") shall also cover any additional shares of ABVC BIOPHARMA, INC. (the "Registrant") Common Stock, par value $0.001 per share ("Common Stock"), which become issuable under the 2026 Equity Incentive Plan pursuant to the Registration Statement by reason of any stock dividend, stock split, recapitalization or any other similar transaction which results in an increase in the number of the Registrant's outstanding shares of Common Stock. These shares consist of (i) 1,169,201 shares, (ii) 4,046,493 shares, representing 15% of the 26,976,625 shares of common stock issued and outstanding as of October 28, 2026, the date the Plan was approved by the stockholders at the special meeting, rounded down to the nearest whole share and (iii) 1,395,229 shares anticipated to become available for issuance on January 1, 2027 pursuant to the Plan's evergreen provision, estimated solely for registration purposes by assuming that the number of shares of Common Stock issued and outstanding as of December 31, 2026 will be 27,904,594 shares, rounded down to the nearest whole share. Estimated solely for purposes of calculating the registration fee. Pursuant to Rule 457(c) and Rule 457(h) under the Securities Act of 1933, the proposed maximum offering price per share and proposed maximum aggregate offering price are based on the reported average of the high and low prices of Common Stock as reported on the Nasdaq Capital Market on November 13, 2026.